Ampleia is a venture-building organization dedicated to support rare diseases therapeutics projects. We work with exceptional scientists and entrepreneurs developing therapeutic options for under-served indications. We act as an operating co-founder from day 1, bringing funding, translational development capabilities and corporate support. We are from each decision to prepare the founders and the company to Series A or strategic deal. We adopt a technology-agnostic approach and work on projects from anywhere in the world." title="" class="btn" data-container="body" data-html="true" data-id="227622" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="Ampleia"> 524
Entity types
Location
1 Rue de l'internationale, 91000 Évry-Courcouronnes, France
Évry-Courcouronnes
France
Employees
Scale: 2-10
Estimated: 6
SIREN
949162317Engaged catalyst
9Added in Motherbase
1 year, 3 months agoDrive the exceptional
Ampleia is a venture-building organization dedicated to support rare diseases therapeutics projects. We work with exceptional scientists and entrepreneurs developing therapeutic options for under-served indications. We act as an operating co-founder from day 1, bringing funding, translational development capabilities and corporate support. We are from each decision to prepare the founders and the company to Series A or strategic deal. We adopt a technology-agnostic approach and work on projects from anywhere in the world.
Biotechnologies, Rare diseases, Lifesciences, and Investments
Drive the exceptional
Ampleia is a venture-building organization dedicated to support rare diseases therapeutics projects. We work with exceptional scientists and entrepreneurs developing therapeutic options for under-served indications. We act as an operating co-founder from day 1, bringing funding, translational development capabilities and corporate support. We are from each decision to prepare the founders and the company to Series A or strategic deal. We adopt a technology-agnostic approach and work on projects from anywhere in the world.
Ampleia is a venture builder dedicated to rare diseases. We support therapeutic research projects to create company and ensure translational development.
Catalyst | Type | Tweets | Articles | |
---|---|---|---|---|
![]() Eurostat European Union, Environmental Services | Eurostat European Union, Environmental Services | Other 28 Feb 2025 | | |
![]() Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 28 Feb 2025 | | |
![]() Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 24 Jun 2024 | | |
![]() | PariSanté Campus | Other 31 Aug 2023 | | |
![]() Genopole Biotechnology, Biotechnology Research | Genopole Biotechnology, Biotechnology Research | Other 30 Apr 2023 | | |
![]() France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 28 Feb 2025 | | |
![]() Takeda Pharmaceutical, Pharmaceutical Manufacturing | Takeda Pharmaceutical, Pharmaceutical Manufacturing | Other 14 Dec 2023 | | |
![]() Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 30 Apr 2023 | | |
![]() | SATT Aquitaine Science Transfert | Other 28 Nov 2023 | |